These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4089057)

  • 21. Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia.
    Rabey JM; Scharf M; Oberman Z; Zohar M; Graff E
    Biol Psychiatry; 1990 Mar; 27(6):581-91. PubMed ID: 2157505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consistent reversal of abnormal DSTs after different antidepressant therapies in a patient with dementia.
    Wamboldt MZ; Kalin NH; Weiler SJ
    Am J Psychiatry; 1985 Jan; 142(1):100-3. PubMed ID: 3966566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone suppression test in borderlines: is it useful?
    Korzekwa M; Steiner M; Links P; Eppel A
    Can J Psychiatry; 1991 Feb; 36(1):26-8. PubMed ID: 2029680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
    Georgotas A; Stokes PE; Krakowski M; Fanelli C; Cooper T
    Biol Psychiatry; 1984 May; 19(5):685-93. PubMed ID: 6733180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F; Gerken A; Steiger A; Fass V
    Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression.
    Grunhaus L; Flegel P; Carroll BJ; Greden JF
    J Affect Disord; 1985; 8(1):1-7. PubMed ID: 3156907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the dexamethasone suppression test distinguish dementia from depression?
    Spar JE; Gerner R
    Am J Psychiatry; 1982 Feb; 139(2):238-40. PubMed ID: 7055301
    [No Abstract]   [Full Text] [Related]  

  • 32. The dexamethasone suppression test in acute grief.
    Shuchter SR; Zisook S; Kirkorowicz C; Risch C
    Am J Psychiatry; 1986 Jul; 143(7):879-81. PubMed ID: 3717428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dexamethasone suppression test in psychotic versus non-psychotic endogenous depression.
    Rihmer Z; Arató M; Szádoczky E; Révai K; Demeter E; György S; Udvarhelyi P
    Br J Psychiatry; 1984 Nov; 145():508-11. PubMed ID: 6498417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone suppression test in depressive stroke patients.
    Dam H; Pedersen HE; Damkjaer M; Ahlgren P
    Acta Neurol Scand; 1991 Jul; 84(1):14-7. PubMed ID: 1927256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A; Frecska E; Rihmer Z; Arató M
    Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of dexamethasone suppression test in early Alzheimer dementia.
    De Leo D; Schifano F; Magni G
    Eur Arch Psychiatry Neurol Sci; 1988; 238(1):19-21. PubMed ID: 3215214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.